---
title: "Crosstree Capital: Expert M&A Advisory for Health Sciences Recapitalization"
description: Crosstree aligns growth-focused firms in the Health Sciences with financial partners who share a common strategic vision due to our deep industry understanding.
---

# Recapitalization Services

### Our experienced senior bankers provide expert recapitalization advisory and execution services to health sciences firms and investors seeking to optimize their capital structure. 

![What We Do - Recap1](https://www.crosstreecapital.com/hubfs/theme-crosstree/images/What%20We%20Do%20-%20Recap1.jpg)

## Expertise from a team you can trust

Our Recapitalization services redefine your business's financial landscape, providing a robust foundation for future growth. With a keen understanding of market dynamics, we tailor comprehensive recapitalization strategies to optimize your capital structure.

Whether you're seeking to enhance liquidity, reduce debt burdens, or fuel expansion initiatives, our industry-focused professionals guide you through a seamless process. Trust us to navigate the complexities of recapitalization, ensuring your business not only survives but thrives in today's dynamic economy.

##### Latest Recapitalization Transactions

[![OpenClinica Completes Growth Recapitalization with Thompson Street Capital Partners to Accelerate Enablement of Clinical Trials](https://www.crosstreecapital.com/hubfs/2024%20-%20Open%20Clinica%20-%20Thompson%20Street%20(1).png)

### OpenClinica Completes Growth Recapitalization with Thompson Street Capital Partners to Accelerate Enablement of Clinical Trials

](https://www.crosstreecapital.com/deals/openclinica-completes-growth-recapitalization-with-thompson-street-capital-partners-to-accelerate-enablement-of-clinical-trials?hsLang=en)

[![RealTime Software Solutions Receives Strategic Investment from LLR Partners to Accelerate Growth and Product Innovation](https://www.crosstreecapital.com/hubfs/2024%20-%20Realtime%20Clinical%20Trial%20-%20LLR%20Partners.png)

### RealTime Software Solutions Receives Strategic Investment from LLR Partners to Accelerate Growth and Product Innovation

](https://www.crosstreecapital.com/deals/realtime-software-solutions-receives-strategic-investment-from-llr-partners-to-accelerate-growth-and-product-innovation?hsLang=en)

[![UpStream Completes $45 Million Funding Round Led by Dragoneer to Revolutionize Care for Older Adults](https://www.crosstreecapital.com/hubfs/2024%20-%20UpStream%20-%20Dragoneer.png)

### UpStream Completes $45 Million Funding Round Led by Dragoneer to Revolutionize Care for Older Adults

](https://www.crosstreecapital.com/deals/upstream-completes-45-million-funding-round-led-by-dragoneer-to-revolutionize-care-for-older-adults?hsLang=en)

[![WIRB-Copernicus Group (“WCG”) recapitalizes, led by Leonard Green & Partners, L.P.](https://www.crosstreecapital.com/hubfs/2024%20-%20WCG%20-%20LGP.png)

### WIRB-Copernicus Group (“WCG”) recapitalizes, led by Leonard Green & Partners, L.P.

](https://www.crosstreecapital.com/deals/wcg-leonardgreenpartners?hsLang=en)

[![Chonometriq Received an Investment from Full In Partners October 1, 2019](https://www.crosstreecapital.com/hubfs/2024%20-%20Chronometriq%20-%20fi.png)

### Chonometriq Received an Investment from Full In Partners October 1, 2019

](https://www.crosstreecapital.com/deals/chonometriq-received-an-investment-from-full-in-partners-october-1-2019?hsLang=en)

[![Biorasi Received a Majority Investment from Riordan, Lewis & Haden Equity Partners November 16, 2018](https://www.crosstreecapital.com/hubfs/2024%20-%20Biorasi%20-%20Riordan%2c%20Lewis%20%26%20Haden.png)

### Biorasi Received a Majority Investment from Riordan, Lewis & Haden Equity Partners November 16, 2018

](https://www.crosstreecapital.com/deals/biorasi-received-a-majority-investment-from-riordan-lewis-haden-equity-partners-november-16-2018?hsLang=en)

[![OmniSeq Received a Strategic Investment from HITACHI April 12, 2018](https://www.crosstreecapital.com/hubfs/2024%20-%20OmniSeq%20-%20Hitachi.png)

### OmniSeq Received a Strategic Investment from HITACHI April 12, 2018

](https://www.crosstreecapital.com/deals/omniseq-received-a-strategic-investment-from-hitachi-april-12-2018?hsLang=en)

[![OmniSeq Received a Strategic Investment from LabCorp August 21, 2017](https://www.crosstreecapital.com/hubfs/2024%20-%20OmniSeq%20-%20LabCorp.png)

### OmniSeq Received a Strategic Investment from LabCorp August 21, 2017

](https://www.crosstreecapital.com/deals/omniseq-received-a-strategic-investment-from-labcorp-august-21-2017?hsLang=en)

[![Chemical Computing Group Received a Majority Investment from Altaris June 8, 2017](https://www.crosstreecapital.com/hubfs/2024%20-%20Chemical%20Computing%20group%20-%20Altaris.png)

### Chemical Computing Group Received a Majority Investment from Altaris June 8, 2017

](https://www.crosstreecapital.com/deals/chemical-computing-group-received-a-majority-investment-from-altaris-june-8-2017?hsLang=en)

![Medsphere Raised $12,000,000 of Senior Debt](https://www.crosstreecapital.com/hubfs/2024%20-%20Medsphere%20-%20Placement%20Agent.png)

### Medsphere Raised $12,000,000 of Senior Debt

![NaviNet Amount Raised Undisclosed, Senior Debt by a Placement Agent](https://www.crosstreecapital.com/hubfs/2024%20-%20NaviNet%20-%20Placement%20Agent.png)

### NaviNet Amount Raised Undisclosed, Senior Debt by a Placement Agent

[![ePharmaSolutions Received a Strategic Investment from Arsenal Capital Partners and WIRB-Copernicus Group September 24, 2014](https://www.crosstreecapital.com/hubfs/2024%20-Epharmasolutions%20-%20WCG.png)

### ePharmaSolutions Received a Strategic Investment from Arsenal Capital Partners and WIRB-Copernicus Group September 24, 2014

](https://www.crosstreecapital.com/deals/epharmasolutions-received-a-strategic-investment-from-arsenal-capital-partners-and-wirb-copernicus-group-september-24-2014?hsLang=en)

[![Endpoint received a strategic investment from Chiltern March 31, 2010](https://www.crosstreecapital.com/hubfs/2024%20-%20Endpoint%20-%20Chiltern.png)

### Endpoint received a strategic investment from Chiltern March 31, 2010

](https://www.crosstreecapital.com/deals/endpoint-received-a-strategic-investment-from-chiltern-march-31-2010?hsLang=en)

[![Micronics raised $6M in Series B Preferred Shares October 16, 2008](https://www.crosstreecapital.com/hubfs/2024%20-%20Micronics.png)

### Micronics raised $6M in Series B Preferred Shares October 16, 2008

](https://www.crosstreecapital.com/deals/micronics-raised-6m-in-series-b-preferred-shares-october-16-2008?hsLang=en)

![Scandius Biomedical amount raised undisclosed preferred Equity Placement Agent](https://www.crosstreecapital.com/hubfs/2024%20-%20Scandius%20-%20Placement%20Agent.png)

### Scandius Biomedical amount raised undisclosed preferred Equity Placement Agent

[![Gentiae Raised $16M in Series B Preferred Shares from Bay City Capital and CIBC January 3, 2007](https://www.crosstreecapital.com/hubfs/2024%20-%20Gentiae%20-%20Baby%20City%20Capital.png)

### Gentiae Raised $16M in Series B Preferred Shares from Bay City Capital and CIBC January 3, 2007

](https://www.crosstreecapital.com/deals/gentiae-raised-16m-in-series-b-preferred-shares-from-bay-city-capital-and-cibc-january-3-2007?hsLang=en)

![Romark Laboratories Amount Raised Undisclosed](https://www.crosstreecapital.com/hubfs/2024%20-%20Romark%20Laboratories%20-%20Placement%20Agent%20(2).png)

### Romark Laboratories Amount Raised Undisclosed

[![Bridge Laboratories Raised $35M in Series B Preferred Shares from Aisling Capital and Lehman Brothers June 14, 2006](https://www.crosstreecapital.com/hubfs/2024%20-%20Bridge%20-%20Aisling%20Capital.png)

### Bridge Laboratories Raised $35M in Series B Preferred Shares from Aisling Capital and Lehman Brothers June 14, 2006

](https://www.crosstreecapital.com/deals/bridge-laboratories-raised-35m-in-series-b-preferred-shares-from-aisling-capital-and-lehman-brothers-june-14-2006?hsLang=en)

![Ixion Biotechnology Inc. Financial advisory](https://www.crosstreecapital.com/hubfs/2024%20-%20Romark%20Laboratories%20-%20Placement%20Agent%20(2)%20(1).png)

### Ixion Biotechnology Inc. Financial advisory

![PBI Financial Advisory](https://www.crosstreecapital.com/hubfs/2024%20-%20Digital%20Healthcare%20-%20Placement%20Agent%20(2)%20(1).png)

### PBI Financial Advisory

[View all deals](https://www.crosstreecapital.com/deals?hsLang=en)

## Connect with your industry's most valuable strategic partners

 Consult Crosstree